Asharq Al-awsat English Middle-east and International News and Opinion from Asharq Al-awsat Newspaper

Max Nisen

Max Nisen

Writer Articles

How Good Is AstraZeneca's Vaccine News?

Max Nisen and Sam Fazeli, who cover the pharmaceutical industry for Bloomberg Opinion and Bloomberg

Why Moderna’s Vaccine Win Is a Giant Leap Against Pandemics

The world now seems likely to have at least two effective vaccines against Covid-19 with Monday's an

New Covid Treatments Are Here, But Who Gets Them?

When it rains good pandemic news, it pours.

Pfizer Vaccine Data Offers Real Pandemic Optimism

Last week I wrote that based on clinical trial math, the earliest looks at coronavirus vaccine data

Health Care’s Boatloads of Cash Are Safe for Now

The 2020 election isn’t entirely settled, but one clear winner has emerged: the health care industri

Stop Waiting on New Covid-19 Treatments. Wear a Mask.

Covid-19 antibody therapies, drugs that mimic the body’s response to infection, have been hailed as

Remdesivir’s Approval for Covid Doesn't Erase Doubts

Gilead Sciences Inc.’s remdesivir, now under the brand name Veklury, reached another milestone Thurs

Covid-19 Tests Are the Real Pandemic Moneymakers

Vaccines and drugs get much of the attention in the scientific race to fight Covid-19.

A Horrifying Covid Chart Still Frightens Months Later

In late June, I highlighted what I deemed a “horrifying” chart showing massive growth in new infecti

J&J Investors Are Fixated on Vaccines Like Everyone Else

The world just got another reminder that vaccine development isn’t easy.

SalivaDirect Could Kick Off a Testing Turnaround in America

Testing failures have weighed down the US Covid-19 response since the virus emerged.

Russia Doesn’t Really Know Whether Its Covid Vaccine Works

Russia is prematurely declaring victory in the race for a vaccine against Covid-19, with potentially

A $2 Billion Bet on Pfizer’s Covid Vaccine Is Worth It

The US just took a step beyond funding Covid-vaccine research toward actively securing shots.

Don't Hype the Hope for Oxford-AstraZeneca Covid Vaccine

After months of hype, the world finally has human trial data from a front-running vaccine collaborat

COVID Leaves Its Mark on Three Health Giants

Health-care earnings season is firmly here, with reports now in from three pillars of the sector: ph


Editor Picks